SCHEMBL9608324

SCHEMBL9608324

C=C(N)c1ccc(Cn2cc3c(c2N(c2ccccc2)C(C)C)c(=O)n(C)c(=O)n3C2CCCC2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.34
MAPT P10636 3/20 0.34
TP53 P04637 1/20 0.34
KDM4E B2RXH2 1/20 0.34
POLB P06746 2/20 0.33
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33
PDE3B Q13370 1/20 0.33
PDE3A Q14432 1/20 0.33
SLC6A2 P23975 3/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
HPD P32754 2/20 0.32
CNR1 P21554 1/20 0.32
CNR2 P34972 1/20 0.32
TSHR P16473 1/20 0.32
CRHBP P24387 1/20 0.32
CRHR2 Q13324 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9609251 0.93 ALDH1A1 (0.34) ALDH1A1MAPTTP53KDM4EPOLB
SCHEMBL9608318 0.67 ALDH1A1 (0.48) ALDH1A1MAPTTP53KDM4EPOLB
SCHEMBL9608346 0.64 PRKDC (0.49) ALDH1A1PIK3CAPRKDC
SCHEMBL13334384 0.63 PRKDC (0.48) PDE4APDE3BPDE1BPIK3CAPRKDC
SCHEMBL9608339 0.59 PDE1A (0.48) ALDH1A1MAPTTP53KDM4EPOLB
SCHEMBL2455867 0.57 PDE1A (0.49) ALDH1A1MAPTTP53KDM4EPOLB
SCHEMBL20861040 0.57 PIK3CA (0.53) ALDH1A1SLC6A2HPDCRHBPCRHR2
SCHEMBL5838061 0.53 DRD2 (0.49) POLBHPDPIK3CAPRKDC
SCHEMBL5838051 0.53 DRD2 (0.52) POLBHPDPIK3CAPRKDC
SCHEMBL6208794 0.53 HPD (0.56) ALDH1A1KDM4ESMN1; SMN2HPDPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150353556-A1 ORGANIC COMPOUNDS LI PENG (US) 2015-12-10 US disclosed
US-8927556-B2 1H-pyrrolo[3,4-D]pyrimidin-2(6H)-one compounds INTRA-CELLULAR THERAPIES, INC. (US) 2015-01-06 US disclosed
US-20120136013-A1 ORGANIC COMPOUNDS INTRA-CELLULAR THERAPIES. INC. 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150353556-A1 ORGANIC COMPOUNDS CYP2C9, TPMT, CYP2C19 ALDH1A1 214/4885MAPT 888/4885TP53 1020/4885
US-20120136013-A1 ORGANIC COMPOUNDS CYP2C9, CYP2C19, CYP3A4 ALDH1A1 216/4885MAPT 966/4885TP53 1249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.